Tailored approaches have been attempted to prevent HBV reinfection in HBsAg-positive liver transplant (LT) recipients in order to minimize the use of hepatitis-B-virus (HBV) specific immunoglobulins (HBIg) and nucleoside analogs (NA). We report the results of complete HBV prophylaxis withdrawal after a follow up of at least 6 years in LT recipients with undetectable serum HBV-DNA and intra-hepatic total HBV-DNA and ccc-DNA at LT.
Lenci, I., Baiocchi, L., Tariciotti, L., Di Paolo, D., Milana, M., Santopaolo, F., et al. (2016). Complete hbv prophylaxis withdrawal in HBsAg-positive liver transplant recipients after long-term minimal immunosuppression. LIVER TRANSPLANTATION [10.1002/lt.24493].
Complete hbv prophylaxis withdrawal in HBsAg-positive liver transplant recipients after long-term minimal immunosuppression
Baiocchi, L;Manzia, TM;SVICHER, VALENTINA;Tisone, G;PERNO, CARLO FEDERICO;ANGELICO, MARIO
2016-06-07
Abstract
Tailored approaches have been attempted to prevent HBV reinfection in HBsAg-positive liver transplant (LT) recipients in order to minimize the use of hepatitis-B-virus (HBV) specific immunoglobulins (HBIg) and nucleoside analogs (NA). We report the results of complete HBV prophylaxis withdrawal after a follow up of at least 6 years in LT recipients with undetectable serum HBV-DNA and intra-hepatic total HBV-DNA and ccc-DNA at LT.| File | Dimensione | Formato | |
|---|---|---|---|
|
2016_Complete hbv prophylaxis withdrawal in HBsAg positive liver transplant recipients after long term minimal immunosuppression Liver Transpl_lenci.pdf
solo utenti autorizzati
Licenza:
Copyright dell'editore
Dimensione
1.72 MB
Formato
Adobe PDF
|
1.72 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
